Recent evidence comparing combination of conventional synthetic disease-modifying antirheumatic drugs with biologic disease-modifying antirheumatic drugs in rheumatoid arthritis by Abhishek Zanwar, Sakir Ahmed, Durga Prasanna Misra, Vikas Agarwal, Aman Sharma, Anupam Wakhlu, Vir Singh Negi

Subjects: “…Biologic disease-modifying antirheumatic drug…”
Get full text

Comparative efficacy of tofacitinib and adalimumab in patients with psoriatic arthritis in real clinical practice. Data from the Russian nationwide register of patients with psoria... by E. Yu. Loginova, T. V. Korotaeva, E. E. Gubar, Yu. L. Korsakova, S. I. Glukhova, E. A. Vasilenko, A. A. Vasilenko, N. A. Kuznetsova, I. M. Patrikeyeva, E. L. Nasonov

Subjects: “…biologic disease-modifying antirheumatic drug…”
Get full text

Conventional disease-modifying agents in rheumatoid arthritis – a review of their current use and role in treatment algorithms by Ivan Padjen, Mirna Reihl Crnogaj, Branimir Anić

Subjects: Get full text

Mangosteen ethanol extract alleviated the severity of collagen-induced arthritis in rats and produced synergistic effects with methotrexate by Jian Zuo, Qin Yin, Lin Wang, Wen Zhang, Yan Fan, Yu-Yan Zhou, Yan Li, Guo-Dong Wang

Subjects: Get full text

Disease Activity in Disease Modifying Anti-Rheumatic Drug (DMARD) Naïve Rheumatoid Arthritis Patients in A Subset of Karachi Population by Dr. Mehreen Inam Illahi, Dr. Sofia Amjad, Dr. Syed Mehfooz Alam, Dr. Syed Tousif Ahmed, Dr. Murk Fatima

Subjects: “…disease modifying antirheumatic drug; Arthritis, Rheumatoid; Rheumatoid Factor; Autoimmune Diseases.…”
Get full text

Geographic Analysis of the Safety and Efficacy of Filgotinib in Rheumatoid Arthritis by Bernard Combe, Robin Besuyen, Antonio Gómez-Centeno, Tsukasa Matsubara, Juan José Sancho Jimenez, Zhaoyu Yin, Maya H. Buch

Subjects: Get full text

Treatment patterns in rheumatoid arthritis patients newly initiated on biologic and conventional synthetic disease-modifying antirheumatic drug therapy and enrolled in a North Amer... by Philip J. Mease, Scott Stryker, Mei Liu, Bob Salim, Sabrina Rebello, Mahdi Gharaibeh, David H. Collier

Subjects: “…Disease-modifying antirheumatic drug…”
Get full text

Managing Disease-Modifying Antirheumatic Drugs (DMARDs) for Patients Undergoing Elective Spine Surgery: A Pilot Survey by James C. Mamaril-Davis, Pedro Aguilar-Salinas, Salvador Fabián Gutiérrez Aguirre, Mauricio J. Avila, Michel Villatoro-Villar, Katherine Riordan, Travis M. Dumont

Subjects: “…disease-modifying antirheumatic drug…”
Get full text

Baseline JAK phosphorylation profile of peripheral blood leukocytes, studied by whole blood phosphospecific flow cytometry, is associated with 1-year treatment response in early rh... by Krista Kuuliala, Antti Kuuliala, Riitta Koivuniemi, Hannu Kautiainen, Heikki Repo, Marjatta Leirisalo-Repo

Subjects: Get full text

Long-Term Safety, Efficacy, and Patient-Centered Outcomes of Filgotinib in the Treatment of Rheumatoid Arthritis: Current Perspectives by Tanaka Y, Genovese MC, Matsushima H

Subjects: Get full text

Abatacept used in combination with non-methotrexate disease-modifying antirheumatic drugs: a descriptive analysis of data from interventional trials and the real-world setting by Rieke Alten, Harald Burkhardt, Eugen Feist, Klaus Krüger, Juergen Rech, Andrea Rubbert-Roth, Reinhard E. Voll, Yedid Elbez, Christiane Rauch

Subjects: “…Conventional synthetic disease-modifying antirheumatic drug…”
Get full text

Patient-Reported Outcomes in Rheumatoid Arthritis: A Key Consideration for Evaluating Biosimilar Uptake? by Horta-Baas G

Subjects: Get full text

Racial and Ethnic Disparities in Treatment Initiation Among Patients with Newly Diagnosed Psoriatic Arthritis: A Retrospective Medicaid Claims Database Study by Aarti A. Patel, Shannon Allen Ferrante, Iris Lin, Alex Z. Fu, Alicia K. Campbell, Arlene Tieng

Subjects: “…Disease-modifying antirheumatic drug…”
Get full text

Bioanalogues in the treatment of rheumatoid arthritis: current status of the problem by N. V. Chichasova, A. M. Lila

Subjects: “…biologic disease-modifying antirheumatic drug…”
Get full text

Ultrasound-detected bone erosion is a relapse risk factor after discontinuation of biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis whose ultras... by Shin-ya Kawashiri, Keita Fujikawa, Ayako Nishino, Akitomo Okada, Toshiyuki Aramaki, Toshimasa Shimizu, Masataka Umeda, Shoichi Fukui, Takahisa Suzuki, Tomohiro Koga, Naoki Iwamoto, Kunihiro Ichinose, Mami Tamai, Akinari Mizokami, Hideki Nakamura, Tomoki Origuchi, Yukitaka Ueki, Kiyoshi Aoyagi, Takahiro Maeda, Atsushi Kawakami

Subjects: “…Biologic disease-modifying antirheumatic drug…”
Get full text

Comparing methotrexate monotherapy with methotrexate plus leflunomide combination therapy in psoriatic arthritis: protocol of a randomized, placebo-controlled, double-blind clinica... by Michelle L. M. Mulder, Johanna E. Vriezekolk, Nathan den Broeder, Elien A. M. Mahler, Philip S. Helliwell, Frank H. J. van den Hoogen, Alfons A. den Broeder, Mark H. Wenink

Subjects: “…Conventional disease-modifying antirheumatic drug (cDMARD)…”
Get full text

Randomised controlled trial of Tumour necrosis factor inhibitors Against Combination Intensive Therapy with conventional disease-modifying antirheumatic drugs in established rheuma... by David L Scott, Fowzia Ibrahim, Vern Farewell, Aidan G O’Keeffe, Margaret Ma, David Walker, Margaret Heslin, Anita Patel, Gabrielle Kingsley

Subjects: Get full text

Sarilumab and adalimumab differential effects on bone remodelling and cardiovascular risk biomarkers, and predictions of treatment outcomes by Cem Gabay, Gerd R. Burmester, Vibeke Strand, Jérôme Msihid, Moshe Zilberstein, Toshio Kimura, Hubert van Hoogstraten, Susan H. Boklage, Jonathan Sadeh, Neil M. H. Graham, Anita Boyapati

Subjects: “…Biologic disease-modifying antirheumatic drug…”
Get full text

Tocilizumab as a first-line biologic treatment in rheumatoid arthritis patients – the impact of concomitant methotrexate treatment and Rheumatic Disease Comorbidity Index on the... by Marcin Stajszczyk, Sławomir Jeka, Anna Juś, Katarzyna Pawlak-Buś

Subjects: Get full text

Editorial: Traditional Medicine and Rheumatology by Zhihua Yang, Xuan Tang, Huasheng Liang, Kaixin Gao, Maojie Wang, Maojie Wang, Maojie Wang, Maojie Wang, Maojie Wang, Xiaojuan He, Per-Johan Jakobsson, Runyue Huang, Runyue Huang, Runyue Huang, Runyue Huang

Subjects: “…disease-modifying antirheumatic drug (DMARD)…”
Get full text